Rock Springs Capital Management as of Dec. 31, 2019
Portfolio Holdings for Rock Springs Capital Management
Rock Springs Capital Management holds 130 positions in its portfolio as reported in the December 2019 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
UnitedHealth (UNH) | 5.5 | $174M | 591k | 293.98 | |
Neurocrine Biosciences (NBIX) | 4.3 | $137M | 1.3M | 107.49 | |
WellCare Health Plans | 3.3 | $106M | 321k | 330.21 | |
Amarin Corporation (AMRN) | 3.1 | $100M | 4.7M | 21.44 | |
Intuitive Surgical (ISRG) | 2.9 | $90M | 153k | 591.15 | |
Johnson & Johnson (JNJ) | 2.6 | $81M | 558k | 145.87 | |
Hca Holdings (HCA) | 2.2 | $69M | 468k | 147.81 | |
Humana (HUM) | 2.1 | $68M | 185k | 366.52 | |
Encompass Health Corp (EHC) | 1.8 | $57M | 815k | 69.27 | |
Boston Scientific Corporation (BSX) | 1.7 | $54M | 1.2M | 45.22 | |
Pacira Pharmaceuticals (PCRX) | 1.6 | $52M | 1.2M | 45.30 | |
Epizyme | 1.6 | $50M | 2.1M | 24.60 | |
Teleflex Incorporated (TFX) | 1.6 | $49M | 130k | 376.44 | |
Insulet Corporation (PODD) | 1.4 | $45M | 261k | 171.20 | |
Sarepta Therapeutics (SRPT) | 1.4 | $45M | 346k | 129.04 | |
Vertex Pharmaceuticals Incorporated (VRTX) | 1.4 | $44M | 203k | 218.95 | |
Baxter International (BAX) | 1.4 | $44M | 525k | 83.62 | |
Edwards Lifesciences (EW) | 1.4 | $43M | 184k | 233.29 | |
Irhythm Technologies (IRTC) | 1.3 | $43M | 624k | 68.09 | |
Alnylam Pharmaceuticals (ALNY) | 1.3 | $42M | 364k | 115.17 | |
Penumbra (PEN) | 1.3 | $40M | 243k | 164.27 | |
Argenx Se (ARGX) | 1.3 | $40M | 248k | 160.52 | |
EXACT Sciences Corporation (EXAS) | 1.2 | $39M | 420k | 92.48 | |
Mirati Therapeutics | 1.2 | $39M | 300k | 128.86 | |
Ardelyx (ARDX) | 1.1 | $36M | 4.9M | 7.50 | |
Galapagos Nv- (GLPG) | 1.1 | $36M | 175k | 206.83 | |
Beigene (BGNE) | 1.1 | $36M | 215k | 165.76 | |
Coherus Biosciences (CHRS) | 1.1 | $35M | 2.0M | 18.01 | |
Ra Pharmaceuticals | 1.1 | $35M | 750k | 46.93 | |
Aprea Therapeutics | 1.1 | $33M | 724k | 45.89 | |
Nevro (NVRO) | 1.0 | $33M | 279k | 117.54 | |
Acadia Healthcare (ACHC) | 1.0 | $32M | 975k | 33.22 | |
Collegium Pharmaceutical Inc Common Stock Usd (COLL) | 1.0 | $32M | 1.6M | 20.58 | |
IDEXX Laboratories (IDXX) | 1.0 | $31M | 120k | 261.13 | |
Align Technology (ALGN) | 1.0 | $31M | 111k | 279.04 | |
Agios Pharmaceuticals (AGIO) | 1.0 | $31M | 642k | 47.75 | |
Assembly Biosciences | 1.0 | $31M | 1.5M | 20.46 | |
Blueprint Medicines (BPMC) | 1.0 | $31M | 382k | 80.11 | |
Amgen (AMGN) | 1.0 | $30M | 126k | 241.07 | |
Axonics Modulation Technolog (AXNX) | 1.0 | $31M | 1.1M | 27.71 | |
Mirum Pharmaceuticals (MIRM) | 1.0 | $31M | 1.2M | 24.52 | |
Ultragenyx Pharmaceutical (RARE) | 0.9 | $30M | 700k | 42.71 | |
Ascendis Pharma A S (ASND) | 0.9 | $30M | 214k | 139.12 | |
ACADIA Pharmaceuticals (ACAD) | 0.9 | $29M | 670k | 42.78 | |
Uniqure Nv (QURE) | 0.9 | $29M | 400k | 71.66 | |
BioMarin Pharmaceutical (BMRN) | 0.9 | $29M | 338k | 84.55 | |
Seattle Genetics | 0.9 | $28M | 242k | 114.26 | |
Thermo Fisher Scientific (TMO) | 0.8 | $26M | 81k | 324.86 | |
Medicines Company | 0.8 | $26M | 308k | 84.94 | |
Deciphera Pharmaceuticals | 0.8 | $26M | 422k | 62.24 | |
Zai Lab (ZLAB) | 0.8 | $26M | 625k | 41.59 | |
Audentes Therapeutics | 0.8 | $25M | 410k | 59.84 | |
West Pharmaceutical Services (WST) | 0.7 | $23M | 153k | 150.33 | |
Madrigal Pharmaceuticals (MDGL) | 0.7 | $23M | 250k | 91.11 | |
Allakos (ALLK) | 0.7 | $22M | 235k | 95.36 | |
Achillion Pharmaceuticals | 0.7 | $22M | 3.7M | 6.03 | |
Incyte Corporation (INCY) | 0.7 | $22M | 250k | 87.32 | |
Portola Pharmaceuticals | 0.7 | $22M | 900k | 23.88 | |
Immunomedics | 0.7 | $21M | 1.0M | 21.16 | |
Global Blood Therapeutics In | 0.7 | $21M | 265k | 79.49 | |
Freshpet (FRPT) | 0.7 | $21M | 355k | 59.09 | |
Radius Health | 0.6 | $20M | 1.0M | 20.16 | |
Intersect Ent | 0.6 | $20M | 800k | 24.90 | |
Invitae (NVTAQ) | 0.6 | $19M | 1.2M | 16.13 | |
Insmed (INSM) | 0.6 | $19M | 800k | 23.88 | |
Forty Seven | 0.6 | $18M | 450k | 39.37 | |
Theravance Biopharma (TBPH) | 0.5 | $17M | 655k | 25.89 | |
Adaptive Biotechnologies Cor (ADPT) | 0.5 | $16M | 545k | 29.92 | |
Healthequity (HQY) | 0.5 | $15M | 205k | 74.07 | |
Cigna Corp (CI) | 0.5 | $15M | 75k | 204.49 | |
Onespaworld Holdings Ltd onespaworld hold (OSW) | 0.5 | $15M | 900k | 16.84 | |
Phreesia (PHR) | 0.5 | $15M | 565k | 26.64 | |
Guardant Health (GH) | 0.5 | $15M | 190k | 78.14 | |
Centene Corporation (CNC) | 0.5 | $14M | 230k | 62.87 | |
Novocure Ltd ord (NVCR) | 0.5 | $15M | 173k | 84.27 | |
Odonate Therapeutics Ord | 0.4 | $14M | 430k | 32.45 | |
Karuna Therapeutics Ord | 0.4 | $14M | 180k | 75.34 | |
Fibrogen (FGEN) | 0.4 | $13M | 306k | 42.89 | |
Zogenix | 0.4 | $13M | 250k | 52.13 | |
Rigel Pharmaceuticals | 0.4 | $12M | 5.5M | 2.14 | |
Myokardia | 0.4 | $12M | 160k | 72.89 | |
Constellation Pharmceticls I | 0.3 | $11M | 234k | 47.11 | |
Biohaven Pharmaceutical Holding | 0.3 | $11M | 200k | 54.44 | |
Arvinas Ord (ARVN) | 0.3 | $10M | 250k | 41.09 | |
Amicus Therapeutics (FOLD) | 0.3 | $9.7M | 1.0M | 9.74 | |
Dermira | 0.3 | $9.9M | 650k | 15.16 | |
Bristol Myers Squibb (BMY) | 0.3 | $9.6M | 150k | 64.19 | |
Dynavax Technologies (DVAX) | 0.3 | $9.0M | 1.6M | 5.72 | |
Medicines Company 2.750000 07/15/2023 bond | 0.3 | $8.8M | 5.0M | 1.75 | |
Homology Medicines | 0.3 | $8.8M | 425k | 20.70 | |
Retrophin | 0.3 | $8.2M | 575k | 14.20 | |
Momenta Pharmaceuticals | 0.2 | $7.9M | 400k | 19.73 | |
Myovant Sciences | 0.2 | $7.8M | 500k | 15.52 | |
Rhythm Pharmaceuticals (RYTM) | 0.2 | $7.9M | 345k | 22.96 | |
Translate Bio | 0.2 | $7.7M | 950k | 8.14 | |
Mersana Therapeutics (MRSN) | 0.2 | $7.1M | 1.2M | 5.73 | |
Phasebio Pharmaceuticals | 0.2 | $6.9M | 1.1M | 6.11 | |
Compugen (CGEN) | 0.2 | $6.6M | 1.1M | 5.96 | |
Intercept Pharmaceuticals In | 0.2 | $6.7M | 54k | 123.92 | |
Ngm Biopharmaceuticals | 0.2 | $6.5M | 351k | 18.49 | |
Galera Therapeutics (GRTX) | 0.2 | $6.6M | 500k | 13.16 | |
Aeglea Biotherapeutics | 0.2 | $6.1M | 800k | 7.64 | |
Chiasma | 0.2 | $5.8M | 1.2M | 4.96 | |
Insmed Inc convertible security | 0.2 | $5.8M | 6.0M | 0.97 | |
Health Catalyst (HCAT) | 0.2 | $5.6M | 160k | 34.70 | |
RTI Biologics | 0.2 | $5.3M | 2.0M | 2.74 | |
10x Genomics Inc Cl A (TXG) | 0.2 | $5.5M | 73k | 76.25 | |
Spero Therapeutics (SPRO) | 0.2 | $5.1M | 525k | 9.62 | |
Akero Therapeutics (AKRO) | 0.2 | $5.0M | 225k | 22.20 | |
Global China Cord Blood Corp (CORBF) | 0.1 | $4.6M | 925k | 5.00 | |
Gamida Cell | 0.1 | $4.3M | 1.0M | 4.30 | |
Bluebird Bio (BLUE) | 0.1 | $3.1M | 35k | 87.74 | |
Aclaris Therapeutics (ACRS) | 0.1 | $3.0M | 1.6M | 1.89 | |
Obseva Sa | 0.1 | $3.0M | 790k | 3.82 | |
Nabriva Therapeutics | 0.1 | $2.8M | 2.1M | 1.32 | |
Macrogenics (MGNX) | 0.1 | $2.5M | 230k | 10.88 | |
Anaptysbio Inc Common (ANAB) | 0.1 | $2.2M | 135k | 16.25 | |
Five Prime Therapeutics | 0.1 | $1.8M | 400k | 4.59 | |
Paratek Pharmaceuticals | 0.1 | $1.5M | 375k | 4.03 | |
Theravance Biopharma Inc note 3.250%11/0 | 0.1 | $1.6M | 1.5M | 1.04 | |
Neurocrine Biosciences Inc Note 2.250 5/1 | 0.1 | $1.5M | 1.0M | 1.54 | |
Radius Health Inc note 3.000% 9/0 | 0.0 | $1.3M | 1.5M | 0.85 | |
Adaptimmune Therapeutics (ADAP) | 0.0 | $960k | 800k | 1.20 | |
Corvus Pharmaceuticals (CRVS) | 0.0 | $816k | 150k | 5.44 | |
Dermira Inc note 3.000% 5/1 | 0.0 | $920k | 1.0M | 0.92 | |
Pacira Pharmaceuticals Inc convertible security | 0.0 | $1.0M | 1.0M | 1.04 | |
Applied Therapeutics (APLT) | 0.0 | $554k | 20k | 27.27 | |
Rts/bristol-myers Squibb Compa | 0.0 | $557k | 185k | 3.01 | |
Pfizer (PFE) | 0.0 | $407k | 10k | 39.13 | |
Covetrus | 0.0 | $273k | 21k | 13.20 |